Table 1 KEGG enrichment analysis for 33 new candidate TFs

hsa05200: Pathways in cancer

E2F3, TCF7, PPARD,

JUN, RXRA, SMAD3,

RARB, GLI2, MYC

5.88E−07

2.29E−05

hsa05223: Non-small cell lung cancer

E2F3, RXRA, RARB,

FOXO3

3.79E−04

0.007373

hsa04310: Wnt signaling pathway

TCF7, PPARD, JUN,

SMAD3, MYC

5.93E−04

0.00768

hsa05210: Colorectal cancer

TCF7, JUN, SMAD3,

MYC

0.001388

0.013451

hsa05222: Small cell lung cancer

E2F3, RXRA, RARB,

MYC

0.001388

0.013451

hsa05216: Thyroid cancer

TCF7, RXRA, MYC

0.002739

0.021169